연구정보
[정책] IPR waiver in vaccines and opportunities for India: what does the data show?
인도 국외연구자료 연구보고서 - ESCAP 발간일 : 2021-10-26 등록일 : 2021-11-12 원문링크
In light of the spread of Covid-19 cases in India during the second wave, the Government of India (GOI) decided to negotiate for an IPR waiver under section 1 (copyright and related rights), 4 (industrial designs), 5 (patents), and 7 (protection of undisclosed information) of TRIPS Agreement under the World Trade Organization (WTO). The expectation of the GOI is that the proposed IPR waiver would allow more firms to come forward to manufacture vaccines, medicines, and other COVID-19 related medical items, which would in turn augment their availability at an affordable price. The current paper concludes that IPR waivers as such are unlikely improve the cheaper access to medicine. Instead, the focus should be on granting of compulsory licenses, reduction of import tariffs and non-tariff measures (NTMs) to reduce prices of COVID-19 medicines, vaccines, and other pharmaceutical items. The analysis with trade data points out India currently lacks a comparative advantage in several categories of active pharmaceutical ingredients, manufacturing medical equipment and devices, disinfectants and sterilisation products, and personal protective equipment. In contrast, it holds a comparative advantage in manufacturing vaccines and formulations. Interestingly, India imposes higher tariffs and NTMs on both sets of products, irrespective of the comparative advantages. The analysis concludes that the focus of the policymakers should be on reduction and elimination of tariffs and NTMs. This will ensure smoother availability of medicinal goods in the domestic market at an affordable price on one hand and augment competitiveness in the world market on the other.
본 페이지에 등재된 자료는 운영기관(KIEP) 및 EMERiCs의 공식적인 입장을 대변하고 있지 않습니다.
| 이전글 | [정책] National Action Plan Promoting Pakistan's Digital Trade Integration in the ... | 2021-11-12 |
|---|---|---|
| 다음글 | [국제관계] The New Challenges in Aid to Afghanistan | 2021-11-12 |
